This Japanese hoverbike and drone stock is exploding

Plus check out the other big movers today                                                                                                                                                                                                                                                                                                                                                                                                                 October 02, 2023 *Together with (NASDAQ: UROY) Good day, 360 – Here are our top investing ideas today – these setups look primed! Be the best prepared trader on the Street! AWIN - Up over 100% in pre-market after announcing it would be considering strategic alternatives including sale ACXP - Up over 20% in pre after Phase 2 trial success for treatment of difficile infection NVTA - Up over 25% in pre after receiving FDA marketing authorization for its “one of a kind” cancer test *A Message on Behalf of Uranium Royalty Corp 🔥 Hot Stock of the Day 🔥 I hope you are not missing it, but there is a new “mega-trend” brewing right now in a sector you probably don’t have on your radar – URANIUM. Let’s face it. There just aren’t enough solar or fossil fuels available right now to supply the global need for more energy. Like it or not, uranium is really the only answer to supply this nearly unquenchable thirst – and savvy investors have been piling in already. While tech stocks have been in the dumps lately, uranium stocks have been breaking out. There is one stock that stands above the rest right now, and that is Uranium Royalty Corp (Nasdaq: UROY). This chart shows the relative outperformance investors in UROY have been seeing since this summer… There is no reason to think that this mega-trend is going to end anytime soon. We think UROY is the best way to ride the “Uranium mega-trend”... with just one stock. This is a stock clearly in “breakout mode,” so time is of the essence. Do your own homework on UROY today and see if you want to ride this mega-trend for yourself… or watch it from the sidelines! *Sponsored by New Era Media. This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results. AWIN - Up over 100% in pre-market after announcing it would be considering strategic alternatives including sale AERWINS Technologies (AWIN) develops and manufactures air mobility platforms in Japan. It also provides a centralized operating system for managing open sky, hoverbikes, and drones; shared computing service; and blockchain verification and AI algorithm generation services. In the after-hours on Friday, [AWIN announced]( that they would be considering strategic alternatives for non-core operations including, not limited to, possible sale/other disposition of assets. Furthermore, the [company announced]( that as part of evaluation, management determined redesigning Xturismo Ltd Edition Prototype 1 would position it more favorablly for wider markets including the U.S. and Europe. It also stated that the company was in discussion with potential joint-venture (JV) partners who are FAA-approved that could “offer an increased level of technical and engineering and financial support that management believes will enable the Company to implement the enhancements to its hoverbike and thus expand its potential to enter new markets.” The stock is up over 100% in pre-market on the news. The $0.24 area was prior resistance and now becomes potential support. Above it, targets to the upside are $0.26 and then the pre-market high at $0.30. Beyond that, $0.34, $0.40, $0.45 and $0.50 come into play. Below $0.24, there is potential support at $0.22, $0.20, $0.18 and then a gap to fill at $0.1208. ACXP - Up over 20% in pre after Phase 2 trial success for treatment of difficile infection Acurx Pharmaceuticals (ACXP) is a clinical stage biopharmaceutical company that develops antibiotics to treat bacterial infections. This morning [the company announced]( the successful completion and early discontinuation of the Ibezapolstat phase 2b trial for treatment of c. difficile infection. The company [stated that](: -Based on observed aggregate blinded data the Company has determined that both treatments, ibezapolstat and the control antibiotic vancomycin, have performed as expected. -High rates of Clinical Cure were observed without any emerging safety concerns. -Data will be analyzed and topline efficacy results will be reported as soon as possible. -This successful milestone will allow advancement of this first-in-class, FDA QIDP/Fast Track-designated antibiotic candidate to Phase 3 clinical trials more expeditiously. The stock is up over 20% in pre-market after the news: The $1.85 area has acted as support so far in the pre-market. Above it, targets are $2, $2.20 and then the pre-market high at $2.44. Beyond that, $2.70, $3 and $3.30 come into play. Below $1.85, there is potential support at $1.77, $1.60 and then a gap to fill at $1.50. NVTA - Up over 25% in pre after receiving FDA marketing authorization for its “one of a kind” cancer test Invitae Corporation (NVTA) is a medical genetics company that provides genetic information to improve healthcare of people in the United States and internationally. The company offers genetic tests in various clinical areas. Late Friday [it was reported]( that the FDA had approved its Invitae Common Hereditary Cancers Panel, a first-of-its-kind test to identify cancer-related genes. Using DNA extracted from a blood sample, the test analyzes 47 genes associated with an elevated risk of developing cancers in the breast, ovary, uterus, prostate, and gastrointestinal system. The stock is up over 25% in pre-market on the news $0.77 was resistance in the pre-market and now becomes potential support. Above it, targets to the upside are $0.80, $.91 and then the pre-market high at $0.9553. Below $0.77, there is potential support at $0.70, $0.68, $0.65 and then a gap to fill at $0.6052. [Economic Calendar]( To Your Success! P.S. Make sure you text “RAGE” to 1-(888) 404-5747 to get all of our latest HOT STOCK ideas (make sure to put the 1 in!). Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull *This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results. Full Disclosures *PAID ADVERTISEMENT. Raging Bull has been paid fifty thousand dollars from New Era Media who was compensated by a third party not affiliated with the Company for advertising Uranium Royalty Corp from a period beginning on October 2 through October 31, 2023. The third party, Company, or their affiliates may own and likely wish to liquidate shares of the Company at or near the time you receive this advertisement, which has the potential to hurt share prices. This advertisement and other marketing efforts, including alerts, may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Uranium Royalty Corp, increased trading volume, and possibly an increased share price of Uranium Royalty Corp, which may or may not be temporary and decrease once the marketing arrangement has ended. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of the issuance of this advertisement, the owners of Raging Bull do not hold a position in Uranium Royalty Corp, though they reserve the right to buy or sell shares in the covered company at any time following the dissemination of this communication. FOR COMMERCIAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for commercial and informational purposes only. A portion of our business is engaged in the promotion, marketing, and advertising of companies including public companies. A portion of Raging Bull’s business model is to receive financial compensation to promote public companies, conduct investor relations advertising and marketing, and publicly disseminate information regarding public companies through our websites email, SMS, and push notifications among other methods of communication. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. All material information contained in this advertisement is based on information generally available to the public, including information released to the public or filed by the Company with applicable regulators which public information is believed to be reliable and accurate. Nevertheless, Raging Bull cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Never invest in any stock featured in this advertisement, on our site or emails unless you can afford to lose your entire investment. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Our advertisements including this advertisement and related emails, reports and alerts may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information in this advertisement, related emails, reports or alerts or on our website or media webpage. This information is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www.sec .gov/edgar/searchedgar/companysearch  TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. WE MAY HOLD SECURITIES DISCUSSED. [Ragingbull.com](, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 2023 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States of America